Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Differential effects of phenobarbital on ester and ether glucuronidation of diflunisal in ratsJ H Lin, I W Chen, E H Ulm, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1981
Sulfoxide reduction. In vitro reduction of sulindac by rat hepatic cytosolic enzymesJ H Ratnayake, P E Hanna, M W Anders, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1987
Urinary excretion kinetics of famotidine in ratsJ H Lin, L E Los, E H Ulm, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990
Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrugS Vickers, C A Duncan, I W Chen, et al.Journal of Pharmaceutical Sciences|March 1, 1977
Analysis of sulindac and metabolites by combined isotope dilution-radioimmunoassayL E Hare, C A Ditzler, M Hichens, et al.Clinical Pharmacology and Therapeutics|August 1, 1975
Bioavailability of oral dexamethasoneD E Duggan, K C Yeh, N Matalia, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1977
Identification of the biologically active form of sulindacD E Duggan, K F Hooke, E A Risley, et al.Journal of Medicinal Chemistry|September 1, 1975
3,5-disubstituted 1,2,3,4-triazoles, 1 new class of xanthine oxidase inhibitorD E Duggan, R M Noll, J E Baer, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1977
The effects of probenecid upon the individual components of indomethacin eliminationD E Duggan, K F Hooke, S D White, et al.Clinical Pharmacology and Therapeutics|September 1, 1975
Bioavailability of dexamethasone. II. Dexamethasone phosphateL E Hare, K C Yeh, C A Ditzler, et al.Pageof 5